Journal Basic Info

  • Impact Factor: 2.709**
  • H-Index: 11 
  • ISSN: 2474-1663
  • DOI: 10.25107/2474-1663
**Impact Factor calculated based on Google Scholar Citations. Please contact us for any more details.

Major Scope

  •  Immunology
  •  General Oncology
  •  Melanoma/Skin Cancer
  •  Ovarian Cancer
  •  Head and Neck Oncology
  •  Blood Cancer
  •  Endometrial Cancer
  •  Radiation Therapy


Citation: Clin Oncol. 2022;7(1):1964.DOI: 10.25107/2474-1663.1964

Two Cases of Thoracic SMARCA4-Deficient Undifferentiated Tumor: A Case Report

Zhang S, Xu W, Wu S, Chen M, Huang J, Sun Q and Zhou Y

Department of Radiation Oncology, First Affiliated Hospital, Bengbu Medical College, China
Department of Pathology, First Affiliated Hospital, Bengbu Medical College, China

*Correspondance to: Yufu Zhou 

 PDF  Full Text Case Report | Open Access


Objective: To investigate the clinical and pathological features of thoracic SMARCA4-deficient undifferentiated tumor.
Methods: The clinical data, images, histopathological features, treatment regimens, and follow-up results of two cases of SMARCA4-deficient undifferentiated tumor diagnosed by clinicians at the First Affiliated Hospital of Bengbu Medical College were retrospectively analyzed.
Results: Both patients were male, aged 65 and 81 years, respectively, and both had a history of smoking. The images showed that both patients had lung masses and mediastinal enlarged lymph nodes. Histopathological analysis revealed that the tumor cells had a solid structure formed by epithelioid/rhabdoid cells, and the tumor cells were distributed in islands or scattered
with extensively necrotic regions, and no evidence of epithelioid differentiation was observed. Immunohistochemical staining demonstrated that the cells were negative for SMARCA4 expression and positive for SOX2 and SMARCB1 expression. The overall survival rates of patients 1 and 2 were 12.0 and 3.2 months, respectively.
Conclusion: Thoracic SMARCA4-deficient undifferentiated tumor is a rare thoracic malignancy, and its diagnosis depends on histopathological and immunohistochemical analyses by experienced pathologists.


Thoracic tumor; SMARCA4; Thoracic SMARCA4-deficient undifferentiated tumor; Immunohistochemistry

Cite the Article:

Zhang S, Xu W, Wu S, Chen M, Huang J, Sun Q, et al. Two Cases of Thoracic SMARCA4-Deficient Undifferentiated Tumor: A Case Report. Clin Oncol. 2022;7:1964..

Search Our Journal

Journal Indexed In

Articles in PubMed

LINGO-1 is a New Therapy Target and Biomarker for Ewing Sarcoma
 PubMed  PMC  PDF  Full Text
NMR Metabolomics in Ionizing Radiation
 PubMed  PMC  PDF  Full Text
View More...

Articles with Grants

Long-Term Follow-Up of Children Treated for Acute Leukemia Focusing on Development of Malignant and Non-Malignant Neoplasms
 Abstract  PDF  Full Text
Enhanced Recovery after Surgery Protocol for Patients Undergoing Radical Cystectomy
 Abstract  PDF  Full Text
View More...